Robert Michael is Chairman of the Board and Chief Executive Officer of AbbVie Inc. (ABBV). The company reported total compensation of $32,530,984 for fiscal year 2025.
| Salary | $1,700,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $13,268,456 |
| Option awards | $3,199,154 |
| Non-equity incentive plan | $5,200,000 |
| Pension and non-qualified deferred compensation | $8,647,081 |
| All other compensation | $516,293 |
| Total | $32,530,984 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure AbbVie Inc. filed March 23, 2026, accession 0001104659-26-033387.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chairman of the Board and Chief Executive Officer | $1,700,000 | $0 | $13,268,456 | $3,199,154 | $5,200,000 | $8,647,081 | $516,293 | $32,530,984 |
| FY2024 | Chairman of the Board and Chief Executive Officer | $1,607,404 | $0 | $7,915,762 | $1,888,269 | $4,590,000 | $2,008,986 | $482,096 | $18,492,517 |
| FY2023 | Chairman of the Board and Chief Executive Officer | $1,427,376 | $0 | $5,440,297 | $1,365,031 | $3,000,000 | $3,019,112 | $189,504 | $14,441,320 |
| FY2022 | Chief Executive Officer | $1,330,000 | $0 | $4,675,204 | $1,099,516 | $2,510,625 | $1,607 | $157,417 | $9,774,369 |
| FY2021 | President and Chief Operating Officer | $1,129,881 | $0 | $4,258,823 | $1,061,733 | $2,630,000 | $2,525,840 | $61,389 | $11,667,666 |
Totals as disclosed in each year's own compensation disclosure for AbbVie Inc..
| Peer-group chief executive median | $27,585,301 |
|---|---|
| Difference from that median | $4,945,683 |
| Percentile within the disclosed peer group | 71st |
| Peers with a disclosed figure | 7 |
Medians and percentiles are computed across the peer group AbbVie Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Robert Michael this page | Chairman of the Board and Chief Executive Officer | $32,530,984 |
| Richard Gonzalez | Executive Chairman of the Board | $17,856,038 |
| Jeffrey Stewart | Executive Vice President, Chief Commercial Officer | $15,435,304 |
| Scott Reents | Executive Vice President, Chief Financial Officer | $12,353,002 |
| Azita Saleki-Gerhardt | Executive Vice President, Chief Operations Officer | $10,791,976 |
| Roopal Thakkar | Executive Vice President, Research & Development and Chief Scientific Officer | $9,912,843 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full AbbVie Inc. compensation brief.
Robert Michael's compensation sits inside AbbVie Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.